LANADELUMAB-FLYO

3228 reported adverse events

Drug classes: Plasma Kallikrein Inhibitor [EPC]

These side effects are most commonly reported by patients taking LANADELUMAB-FLYO:

# Side effect Count
0 HEREDITARY ANGIOEDEMA 1217
1 DRUG INEFFECTIVE 298
2 PRODUCT DOSE OMISSION ISSUE 265
3 WEIGHT INCREASED 245
4 WEIGHT DECREASED 238
5 HEADACHE 188
6 CONDITION AGGRAVATED 187
7 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 169
8 PRODUCT USE ISSUE 161
9 INTENTIONAL PRODUCT USE ISSUE 157
See all common reactions for LANADELUMAB-FLYO

LANADELUMAB-FLYO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ACCESS SITE COMPLICATION 60 0.2381
1 HEREDITARY ANGIOEDEMA 1217 0.1133
2 BODY HEIGHT INCREASED 34 0.0694
3 BODY HEIGHT ABNORMAL 4 0.0345
4 LARYNGEAL DISORDER 17 0.0235
5 VEIN COLLAPSE 13 0.0169
6 RESPIRATORY TRACT OEDEMA 11 0.0148
7 CENTRAL VENOUS CATHETER REMOVAL 6 0.0128
8 PHARYNGEAL SWELLING 123 0.0126
9 ADMINISTRATION SITE PAIN 13 0.0113
See all enriched reactions for LANADELUMAB-FLYO